Articles from Business Wire (June 3, 2007)

Title	Author	Type	Words
Alliant Insurance Services to Be Acquired by Blackstone and Management.			633
ARIAD Presents Additional Efficacy Data on AP23573, Novel mTOR Inhibitor, in Phase 2 Advanced Sarcoma Trial.			1113
ARIAD Presents Positive Efficacy Data On AP23573, Novel mTOR Inhibitor, in Phase 2 Metastatic Endometrial Cancer Trial.			1353
Bruker Daltonics Introduces Unique TargetAnalysis(TM) Solution for Multi-target Screening in Forensics, Environmental Testing and Food Analysis.			341
Bruker Daltonics Launches Unique ImagePrep(TM) Matrix Deposition Device for MALDI Molecular Imaging in Biomarker Discovery, Drug Imaging and Pathology Research.			344
Data Show Improved Response Rate When Zevalin Plus Rituximab Follows Short Course First-Line Treatment in Patients with Follicular Lymphoma.			987
Genentech Provides Update on Pipeline Agents at the American Society of Clinical Oncology Meeting.			1558
ImmunoGen, Inc. Announces Clinical Data Reported at ASCO.			1601
LexisNexis Releases Survey on Information Professionals Use of Web 2.0 and Knowledge Management to Add Value to Their Organizations.			746
New PetIntact Product Helps Pets Live Longer, Healthier Lives.			348
Patients Who Took Investigational Melanoma Compound CP-675,206 Showed Favorable Survival Outcomes, Pfizer Says.			712
Perceptive Impression: Dialing for Dollars: Top Model Sues AT&T for Multi Billion Dollar Technology.			329
Resolution Revolution: Siemens Unveils World's First High Definition PET-CT, Providing Unprecedented Clarity Through Entire Field of View.			775
Single-Agent SUTENT Prolonged Progression-Free Survival across All Advanced Kidney Cancer Patient Risk Groups, Including Those with Poorest Prognoses, Data Show.			1105
Xanthus Announces Phase 1 Results for P2045 - a Targeted Agent for Non-Small Cell Lung Cancer.		Financial report	756
ZIO-301 (Indibulin) Interim Phase I Data Presented at ASCO.			675